3D Medicines Inc. (1244.HK)

HKD 3.49

(4.18%)

Total Liabilities Summary of 3D Medicines Inc.

  • 3D Medicines Inc.'s latest annual total liabilities in 2023 was 558.19 Million CNY , up 27.84% from previous year.
  • 3D Medicines Inc.'s latest quarterly total liabilities in 2024 Q1 was 490.66 Million CNY , down -12.1% from previous quarter.
  • 3D Medicines Inc. reported annual total liabilities of 436.64 Million CNY in 2022, down -86.9% from previous year.
  • 3D Medicines Inc. reported annual total liabilities of 3.33 Billion CNY in 2021, up 88.72% from previous year.
  • 3D Medicines Inc. reported quarterly total liabilities of 490.66 Million CNY for 2024 Q1, down -12.1% from previous quarter.
  • 3D Medicines Inc. reported quarterly total liabilities of 558.19 Million CNY for 2023 Q3, up 6.6% from previous quarter.

Annual Total Liabilities Chart of 3D Medicines Inc. (2023 - 2020)

Historical Annual Total Liabilities of 3D Medicines Inc. (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 558.19 Million CNY 27.84%
2022 436.64 Million CNY -86.9%
2021 3.33 Billion CNY 88.72%
2020 1.76 Billion CNY 0.0%

Peer Total Liabilities Comparison of 3D Medicines Inc.

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -265.269%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 92.091%